Q1 2010

Filed Aug 13, 2010 · 10-Q · 44 days after period end · 0001393905-10-000437

Q1 2010 · 10-Q

Revenue

$733.92K

no prior Q1 2009 on file

Net Income

-$981.63K

no prior Q1 2009 on file

EPS Diluted

-$0.19

no prior Q1 2009 on file

Operating Income-$460,969—

Operating Cash Flow

Same quarter

no prior Q1 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2010 · filed Aug 13, 2010 · 44 d after period end

Vistagen Therapeutics, Inc. · CIK 1411685 · Engraved from SEC EDGAR